Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination - Wikidata - awgldk - TriplyDB

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

http://www.wikidata.org/entity/Q23911235

about

sameAs

Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: methodology and recommendations Antineoplastic drugs and their analysis: a state of the art review.New approaches to wipe sampling methods for antineoplastic and other hazardous drugs in healthcare settings.

P2860

Q23922577-9946764F-77C2-4A31-AE30-3AC3C59C488A Q39339684-EBE1F561-AB58-4883-9ED8-81CF1E4AFDAD Q54328762-106012B2-AD50-4C25-9020-7B3964442ED6

P2860

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

http://www.wikidata.org/entity/Q23911235

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@ast

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@en

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@en-gb

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@nl

type

label

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@ast

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@en

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@en-gb

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@nl

prefLabel

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@ast

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@en

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@en-gb

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@nl

P1433

Q23911235-5EE67725-0114-4D81-A60E-0B6FBA2D0FC0

P1476

Q23911235-7C7EA2B9-04A5-435B-9427-A595799C12D6

P2093

Q23911235-A26886AA-08A9-49A9-89B6-48CCE5EB2475

Q23911235-A3D8814F-1F31-4680-8973-7C80053BF18C

Q23911235-A9392E7C-251E-486B-B234-FEF9ED594FAD

Q23911235-B7F62443-5323-4CBC-80FE-5457C66CD315

P2860

Q23911235-0FE4C142-C265-4C9B-A5A7-F7E9FE6F49CA

Q23911235-14526F5C-DDB8-4D5D-96B9-77D721E98367

Q23911235-37FCA612-5D52-4EDD-A374-E079AD536DF5

Q23911235-44179EE2-A21D-4F10-8193-6D3B5EC48A6E

Q23911235-4BE9330A-7D0D-4ACB-8D62-628820E76512

Q23911235-4EAFA69C-2E7A-4DB0-94FC-6B721AA72EAD

Q23911235-727F6C5B-04DD-475D-BAD5-896B427FBBD3

Q23911235-D7F59925-603D-489E-900F-A6ED4D7A57F7

Q23911235-DA80D893-EAC3-4239-BCAC-F8467D6E9B07

Q23911235-E75165A6-4BB2-4A5A-8A26-7F2B8510A899

P2880

Q23911235-7922A919-89DD-4531-AC19-674A8586DA11

P304

Q23911235-85D445DB-23E1-455B-8388-9432041A1652

P31

Q23911235-CF4A4F60-71B9-4B40-88AD-2F0F94955E67

P356

Q23911235-FD6F04EE-42A4-4700-9F78-44DFAB99CE9D

P407

Q23911235-55D29C3C-1C04-46D1-9EA1-AC3987B54342

P433

Q23911235-FA70D58F-6CFF-4EAC-A06D-C27245715901

P478

Q23911235-359D84AF-046F-4FA9-B03B-DC302277B052

P577

Q23911235-CE460E76-ED85-4C34-9545-6B48DE2A9CAC

P698

Q23911235-93F0B15F-B489-4F9A-9EDD-F8BF910A7ECE

P859

Q23911235-E451EC76-ABFA-4C2C-B172-15AF24BC8FDC

P921

Q23911235-3124A225-1418-4597-BCBD-8078554E8111

Q23911235-68D9B706-23B3-48F1-896C-5383D95072D5

P932

Q23911235-3FB36265-BD0B-4054-87A6-468414A78FE0

P356

P1433

Journal of Chromatographic Science

P1476

Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination

@en

P2093

Clayton B'Hymer

http://www.w3.org/2001/XMLSchema#string

Derek Stinson

http://www.w3.org/2001/XMLSchema#string

Jack Pretty

http://www.w3.org/2001/XMLSchema#string

Thomas Connor

http://www.w3.org/2001/XMLSchema#string

P2860

Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment

Monitoring method for surface contamination caused by selected antineoplastic agents

The mitomycin C (MMC)-binding protein from MMC-producing microorganisms protects from the lethal effect of bleomycin: crystallographic analysis to elucidate the binding mode of the antibiotic to the protein

Mitomycin, a new antibiotic from Streptomyces. I.

Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy.

Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge.

Hyperthermic intraperitoneal chemotherapy: methodology and safety considerations.

Evaluation of the stability of extemporaneously prepared ophthalmic formulation of mitomycin C.

Mitomycin C bladder instillation therapy for bladder tumors.

Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma.

P2880

20045056

http://www.w3.org/2001/XMLSchema#string

P304

619-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CHROMSCI/BMU095

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25129062

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

isopropyl alcohol

P932

4556226

http://www.w3.org/2001/XMLSchema#string